Metabolomic approaches in the discovery of potential urinary biomarkers of drug-induced liver injury (DILI)
Drug-induced liver injury (DILI) is a major safety issue during drug development, as well as the most common cause for the withdrawal of drugs from the pharmaceutical market. The identification of DILI biomarkers is a labor-intensive area. Conventional biomarkers are not specific and often only appe...
| Autor principal: | |
|---|---|
| Outros Autores: | , , , |
| Formato: | article |
| Idioma: | eng |
| Publicado em: |
2021
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/10284/10036 |
| País: | Portugal |
| Oai: | oai:bdigital.ufp.pt:10284/10036 |